Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Nevoid basal cell carcinoma syndrome (NBCCS) or Gorlin syndrome (CROSBI ID 85977)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Levanat, Sonja ; Šitum, Mirna ; Lipozenčić, Jasna Nevoid basal cell carcinoma syndrome (NBCCS) or Gorlin syndrome // Acta Dermatovenerologica Croatica, 7 (1999), 1; 11-17

Podaci o odgovornosti

Levanat, Sonja ; Šitum, Mirna ; Lipozenčić, Jasna

engleski

Nevoid basal cell carcinoma syndrome (NBCCS) or Gorlin syndrome

Gorlin Syndrome or Nevoid Basal Cell Carcinoma Syndrome (NBCCS) or Gorlin-Goltz syndrome is a rare autosomal dominant disorder characterized by predisposition to wide variety of tumors ( basocellular carcinomas(BCCs) are with highest frequency, ovarian fibroma and medulloblastoma) and developmental defects (jaw keratocysts are most frequent, then bifid ribs, pits of palms and soles, ectopic calcifications etc). Recently Gorlin syndrome gene was identified as PTCH or patched. PTCH mutations were found in various tumors and keratocysts related to the syndrome. It is accepted that PTCH is a tumor suppressor for BCC and medulloblastoma. Its gene product is a membrane receptor, a part of new signalling pathway (hedgehog /patched pathway). PTCH is only one known tumor suppressor whose mutacions contribute to tumor development and to wide variety of malformations, and it is probabbly tumor suppressor which plays important role in during development.

Gorlin syndrome; NBCCS; tumor supresors; malformations; tumors

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

7 (1)

1999.

11-17

objavljeno

1330-027X

1847-6538

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost